A molecule that helps some cancers evade the immune system may also help the tumor itself grow, according to research highlighted this month by Augusta University.

The Georgia Cancer Center team, led by Anatolij Horuzsko, studied HLA-G in clear-cell renal cell carcinoma. Its paper in OncoImmunology combines analyses of human tumor data and specimens with laboratory cell studies and mouse tumor models.

Cells engineered to express HLA-G showed greater growth and resistance to cell death. The researchers also found effects on immune-cell behavior, supporting the idea that the molecule acts both inside the tumor and on its surroundings.

Those findings identify a research target, not a treatment ready for patients. The university’s November 10 account stresses that additional work is needed to determine whether blocking HLA-G could be safe and effective in people.

The paper was published online August 13; November 10 was the university’s news report. Two Summer Research Experience participants, Useong Chang and Mia Lin, are among the authors.